Fitness loss under amino acid starvation in artemisinin-resistant Plasmodium falciparum isolates from Cambodia
Artemisinin is the most rapidly effective drug for Plasmodium falciparum malaria treatment currently in clinical use. Emerging artemisinin-resistant parasites pose a great global health risk. At present, the level of artemisinin resistance is still relatively low with evidence pointing towards a tra...
Main Authors: | Bunditvorapoom, D, Kochakarn, T, Kotanan, N, Modchang, C, Kümpornsin, K, Loesbanluechai, D, Krasae, T, Cui, L, Chotivanich, K, White, N, Wilairat, P, Miotto, O, Chookajorn, T |
---|---|
Format: | Journal article |
Published: |
Nature Research
2018
|
Similar Items
-
Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage
by: Kümpornsin, K, et al.
Published: (2021) -
Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
by: Loesbanluechai, D, et al.
Published: (2018) -
Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites.
by: Ponsuwanna, P, et al.
Published: (2016) -
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.
by: Miotto, O, et al.
Published: (2013) -
A nuclear targeting system in <it>Plasmodium falciparum</it>
by: Kochakarn Theerarat, et al.
Published: (2010-05-01)